France CPAP Devices Market
Market Report I 2026-01-01 I 350 Pages I Data Bridge Market Research
The France CPAP Devices Market is expected to reach USD 421.7 Million by 2033 from USD 262.76 Million in 2025, growing with a CAGR of 6.2% in the forecast period of 2026 to 2033.
Market Segmentation:
France CPAP Devices Market, By Product Type (CPAP Device, Consumable), Application Area (Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Obesity Hypoventilation Syndrome (OHS), Asthma, Bronchiolitis, Others), Modality (Standalone, Portable), End User (Home Care, Hospitals, Private Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2033
Overview of France CPAP Devices Market Dynamics:
Drivers
- Rising prevalence of sleep apnea and COPD
- High healthcare spending
- Rising aging demographics.
Restraints
- High device & accessory costs
- Regulatory complexity & approval delays.
Opportunitites
- Expanding telemedicine & remote monitoring
- Growing homecare & outpatient clinics network
- Technological advancements in cpap devices
Challenges
- Supply chain & component shortages
- Patient Non-Adherence
Market Players:
The key players operating in the France CPAP Devices Market are:
- Hamilton (U.S.)
- Nareena Lifesciences (India)
- Fisher & Paykel Healthcare Limited (New Zealand)
- BMC Medical Co., Ltd. (China)
- WELLELL Inc. (Taiwan)
- Fritz Stephan GmbH (Germany)
- Vygon ( Germany )
- Lowenstein Medical SE & Co. KG (Germany)
- SOMNOmedics AG (Germany)
- CVR Medical Supply (U.S.)
- Kranz GmbH (Germany)
- Koninklijke Philips N.V. (Netherlands)
- GE HealthCare (U.S.)
- ECUMED GmbH (Germany)
- Boppel.Med (Germany)
- Narang Medical Limited (India)
- Heyer Medical AG (Germany)
- Hunan Beyond Medical Technology Co., Ltd. (China)
- NIHON KOHDEN CORPORATION (Japan)
- WEINMANN Emergency Medical Technology (Germany)
- SEFAM Medical ( Germany )
- ResMed Inc. (U.S.).
TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP DEVICES MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 CURRENCY AND PRICING 25
2.5 DBMR TRIPOD DATA VALIDATION MODEL 26
2.6 MULTIVARIATE MODELLING 29
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30
2.8 DBMR MARKET POSITION GRID 31
2.9 DBMR VENDOR SHARE ANALYSIS 32
2.10 MARKET END USER COVERAGE GRID 33
2.11 SECONDARY SOURCES 34
2.12 ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHTS 41
4.1 PESTEL ANALYSIS 42
4.1.1 POLITICAL FACTORS 42
4.1.2 ECONOMIC FACTORS 42
4.1.3 SOCIAL FACTORS 43
4.1.4 TECHNOLOGICAL FACTORS 43
4.1.5 LEGAL FACTORS 43
4.1.6 ENVIRONMENTAL FACTORS 43
?
4.2 OPPORTUNITY MAP ANALYSIS 44
4.2.1 INTRODUCTION 44
4.2.2 HEALTHCARE EXPENDITURE 44
4.2.3 CAPITAL EXPENDITURE 45
4.2.4 CAPEX TRENDS 46
4.2.5 CAPEX ALLOCATION 46
4.2.6 FUNDING SOURCES 47
4.2.7 INDUSTRY BENCHMARKS 48
4.2.8 HEALTHCARE SPENDING AS RATIO OF OVERALL GDP 48
4.2.9 HEALTHCARE SYSTEM STRUCTURE 49
4.2.10 GOVERNMENT POLICIES 49
4.2.11 ECONOMIC DEVELOPMENT 50
4.3 INDUSTRY INSIGHTS 51
4.3.1 MICRO AND MACRO ECONOMIC FACTORS 51
4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 51
4.3.3 KEY PRICING STRATEGIES 52
4.3.4 INTERVIEWS WITH SPECIALISTS 52
4.3.5 ANALYSIS AND RECOMMENDATIONS 52
4.4 COST ANALYSIS BREAKDOWN 53
4.4.1 INTRODUCTION 53
4.4.2 MARKET COST STRUCTURE OVERVIEW 53
4.4.3 DEVICE ACQUISITION COST ANALYSIS 53
4.4.4 MASK AND CONSUMABLES COST DYNAMICS 54
4.4.5 SERVICE AND FOLLOW-UP COST ASSESSMENT 54
4.4.6 REIMBURSEMENT IMPACT ON NET COST 54
4.4.7 TOTAL COST OF OWNERSHIP (TCO) ANALYSIS 55
4.4.8 STRATEGIC MARKET IMPLICATIONS 55
4.4.9 CONCLUSION 55
4.5 OPPORTUNITY MAP ANALYSIS 56
4.5.1 INTRODUCTION 56
4.5.2 OPPORTUNITY LANDSCAPE ACROSS DISEASE AWARENESS AND DIAGNOSIS PATHWAYS 56
4.5.3 OPPORTUNITY MAPPING BY THERAPY ADHERENCE AND LONG-TERM COMPLIANCE GAPS 57
4.5.4 OPPORTUNITY MAPPING BY HOMECARE AND DECENTRALIZED CARE EXPANSION 58
4.5.5 OPPORTUNITY MAPPING BY TECHNOLOGY DIFFERENTIATION AND DIGITAL INTEGRATION 58
4.5.6 OPPORTUNITY MAPPING BY REIMBURSEMENT EVOLUTION AND VALUE-BASED CARE 59
4.5.7 CONCLUSION 59
?
4.6 REIMBURSEMENT FRAMEWORK FOR CPAP DEVICES 62
4.6.1 INTRODUCTION 62
4.6.2 ELIGIBILITY CRITERIA AND DIAGNOSTIC PATHWAYS 62
4.6.3 DEVICE COVERAGE STRUCTURE AND COST COMPONENTS 63
4.6.4 ROLE OF HEALTHCARE PROVIDERS AND DISTRIBUTION CHANNELS 64
4.6.5 ADHERENCE MONITORING AND CONDITIONAL REIMBURSEMENT 64
4.6.6 PATIENT COST SHARING AND FINANCIAL RESPONSIBILITY 65
4.6.7 CONCLUSION 65
4.7 SUPPLY CHAIN ECOSYSTEM 69
4.7.1 PROMINENT COMPANIES 69
4.7.2 SMALL & MEDIUM SIZE COMPANIES 70
4.7.3 END USERS 70
4.8 TECHNOLOGY ROADMAP 71
4.8.1 INTRODUCTION 71
4.8.2 SHORT-TERM ROADMAP (2024-2026): CONNECTIVITY, COMFORT, AND COMPLIANCE 71
4.8.2.1 CORE TECHNOLOGY TRENDS 71
4.8.2.2 DIGITAL CONNECTIVITY INTEGRATION 71
4.8.2.3 COUNTRY DIFFERENTIATION 71
4.8.3 MID-TERM ROADMAP (2026-2029): AI-DRIVEN THERAPY OPTIMIZATION AND ECOSYSTEM INTEGRATION 71
4.8.3.1 ARTIFICIAL INTELLIGENCE AND PREDICTIVE ANALYTICS 71
4.8.3.2 INTEGRATION WITH DIGITAL HEALTH ECOSYSTEMS 72
4.8.3.3 REMOTE CARE AND HOMECARE AUTOMATION 72
4.8.3.4 COUNTRY DIFFERENTIATION 72
4.8.4 LONG-TERM ROADMAP (2029-2035): PREVENTIVE SLEEP MEDICINE AND THERAPY CONVERGENCE 72
4.8.4.1 THERAPY CONVERGENCE AND HYBRID DEVICES 72
4.8.4.2 PREDICTIVE POPULATION HEALTH APPLICATIONS 72
4.8.4.3 MINIATURIZATION AND LIFESTYLE INTEGRATION 72
4.8.5 REGULATORY AND REIMBURSEMENT INFLUENCE ON THE ROADMAP 72
4.8.6 STRATEGIC IMPLICATIONS FOR MANUFACTURERS 73
4.8.7 CONCLUSION 73
4.9 COMPANY EVALUATION QUADRANT 74
4.10 INNOVATION TRACKER AND STRATEGIC ANALYSIS 75
4.10.1 INTRODUCTION 75
4.10.2 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 75
4.10.2.1 JOINT VENTURES 75
4.10.2.2 MERGERS AND ACQUISITIONS 76
4.10.2.3 LICENSING AND PARTNERSHIPS 77
4.10.2.4 TECHNOLOGY COLLABORATIONS 77
4.10.2.5 STRATEGIC DIVESTMENTS 78
4.10.3 NUMBER OF PRODUCTS IN DEVELOPMENT 78
4.10.4 STAGE OF DEVELOPMENT 79
4.10.5 TIMELINES AND MILESTONES 79
4.10.6 INNOVATION STRATEGIES AND METHODOLOGIES 79
4.10.7 RISK ASSESSMENT AND MITIGATION 80
4.10.8 FUTURE OUTLOOK 80
5 SALES VOLUME PER PLAYER IN THE SWITZERLAND, FRANCE, ITALY AND GERMANY (UNIT) 81
6 REGULATORY COMPLIANCE ANALYSIS 82
6.1 INTRODUCTION 82
6.2 REGULATORY AUTHORITIES 83
6.3 REGULATORY CLASSIFICATIONS 84
6.4 REGULATORY SUBMISSIONS 84
6.5 CONCLUSION 86
7 MARKET OVERVIEW 88
7.1 DRIVERS 90
7.1.1 RISING PREVALENCE OF SLEEP APNEA AND COPD 90
7.1.2 HIGH HEALTHCARE SPENDING 91
7.1.3 RISING AGING DEMOGRAPHICS 92
7.2 RESTRAINTS 93
7.2.1 HIGH DEVICE & ACCESSORY COSTS 93
7.2.2 REGULATORY COMPLEXITY & APPROVAL DELAYS 94
7.3 OPPORTUNITIES 95
7.3.1 EXPANDING TELEMEDICINE & REMOTE MONITORING 95
7.3.2 GROWING HOMECARE & OUTPATIENT CLINICS NETWORK 96
7.3.3 TECHNOLOGICAL ADVANCEMENTS IN CPAP DEVICES 97
7.4 CHALLENGES 98
7.4.1 SUPPLY CHAIN & COMPONENT SHORTAGES 98
7.4.2 PATIENT NON-ADHERENCE 98
?
8 SWITZERLAND, FRANCE, ITALY, AND GERMANY CPAP DEVICES MARKET, BY PRODUCT TYPE 100
8.1 OVERVIEW 101
8.2 CPAP DEVICE 104
8.2.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP DEVICE IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 104
8.2.1.1 AUTO-ADJUSTING CPAP DEVICES 105
8.2.1.1.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP DEVICE IN CPAP DEVICES MARKET, BY AUTOMATION, 2018-2033 (USD THOUSAND) 105
8.2.1.1.1.1 AUTOMATIC 105
8.2.1.1.1.2 MANUAL 105
8.2.1.2 FIXED PRESSURE CPAP DEVICES 105
8.2.1.3 TRAVEL CPAP DEVICES 105
8.3 CONSUMABLE 106
8.3.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND CONSUMABLE IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 106
8.3.1.1 CPAP MASK 106
8.3.1.1.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP MASK IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 107
8.3.1.1.1.1 NASAL MASKS 107
8.3.1.1.1.2 FULL-FACE MASKS 107
8.3.1.1.1.3 NASAL PILLOW MASKS 107
8.3.1.2 CPAP HOSES 108
8.3.1.3 HUMIDIFIER WATER CHAMBERS 108
8.3.1.4 CPAP FILTERS 108
8.3.1.4.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP FILTERS IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 108
8.3.1.4.1.1 DISPOSABLE FILTERS 108
8.3.1.4.1.2 REUSABLE FILTERS 108
8.3.1.5 CPAP MOTORS 109
8.3.1.6 CHIN STRAPS 109
8.3.1.7 OTHERS 109
?
9 SWITZERLAND, FRANCE, ITALY, AND GERMANY CPAP DEVICES MARKET, BY APPLICATION AREA 110
9.1 OVERVIEW 111
9.2 SLEEP APNEA 114
9.2.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND SLEEP APNEA IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 115
9.2.1.1 OBSTRUCTIVE SLEEP APNEA 115
9.2.1.2 CENTRAL SLEEP APENA 115
9.2.1.3 MIXED SLEEP APENA 115
9.3 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 115
9.4 OBESITY HYPOVENTILATION SYNDROME (OHS) 115
9.5 ASTHMA 116
9.6 BRONCHIOLITIS 116
9.7 OTHERS 116
10 SWITZERLAND, FRANCE, ITALY, AND GERMANY CPAP DEVICES MARKET, BY MODALITY 117
10.1 OVERVIEW 118
10.2 STANDALONE 120
10.3 PORTABLE 120
11 SWITZERLAND, FRANCE, ITALY, AND GERMANY CPAP DEVICES MARKET, BY END USER 121
11.1 OVERVIEW 122
11.2 HOME CARE 124
11.2.1 SWITZERLAND, FRANCE, ITALY, AND GERMANY HOME CARE IN CPAP DEVICES MARKET, BY MODALITY, 2018-2033 (USD THOUSAND) 125
11.2.1.1 STANDALONE 125
11.2.1.2 PORTABLE 125
11.3 HOSPITALS 125
11.3.1 SWITZERLAND, FRANCE, ITALY, AND GERMANY HOSPITALS IN CPAP DEVICES MARKET, BY MODALITY, 2018-2033 (USD THOUSAND) 125
11.3.1.1 STANDALONE 126
11.3.1.2 PORTABLE 126
11.4 PRIVATE CLINICS 126
11.4.1 SWITZERLAND, FRANCE, ITALY, AND GERMANY PRIVATE CLINICS IN CPAP DEVICES MARKET, BY MODALITY, 2018-2033 (USD THOUSAND) 126
11.4.1.1 STANDALONE 127
11.4.1.2 PORTABLE 127
?
11.5 OTHERS 127
11.5.1 SWITZERLAND, FRANCE, ITALY, AND GERMANY OTHERS IN CPAP DEVICES MARKET, BY MODALITY, 2018-2033 (USD THOUSAND) 127
11.5.1.1 STANDALONE 127
11.5.1.2 PORTABLE 127
12 SWITZERLAND, FRANCE, ITALY, AND GERMANY CPAP DEVICES MARKET, BY DISTRIBUTION CHANNEL 128
12.1 OVERVIEW 129
12.2 DIRECT TENDER 132
12.3 RETAIL SALES 132
12.3.1 GERMANY, FRANCE, ITALY, AND SWITZERLAND RETAIL SALES IN CPAP DEVICES MARKET, BY TYPE, 2018-2033 (USD THOUSAND) 133
12.3.1.1 OFFLINE 133
12.3.1.2 ONLINE 133
12.4 OTHERS 133
13 GERMANY, FRANCE, ITALY, AND SWITZERLAND CPAP DEVICES MARKET, BY COUNTRY 134
13.1 OVERVIEW 135
13.2 GERMANY 138
13.3 FRANCE 144
13.4 ITALY 150
13.5 SWITZERLAND 156
14 GERMANY, SWITZERLAND, FRANCE, ITALY CPAP DEVICES MARKET: COMPANY LANDSCAPE 162
14.1 COMPANY SHARE ANALYSIS: GERMANY, SWITZERLAND, FRANCE, ITALY 162
15 SWOT ANALYSIS 163
16 COMPANY PROFILES 164
16.1 RESMED 164
16.1.1 COMPANY SNAPSHOT 164
16.1.2 REVENUE ANALYSIS 164
16.1.3 PRODUCT PORTFOLIO 165
16.1.4 RECENT UPDATES 173
16.2 FISHER & PAYKEL HEALTHCARE LIMITED 177
16.2.1 COMPANY SNAPSHOT 177
16.2.2 REVENUE ANALYSIS 177
16.2.3 PRODUCT PORTFOLIO 178
16.2.4 RECENT DEVELOPMENT 179
16.3 KONINKLIJKE PHILIPS N.V. 180
16.3.1 COMPANY SNAPSHOT 180
16.3.2 REVENUE ANALYSIS 180
16.3.3 PRODUCT PORTFOLIO 181
16.3.4 RECENT DEVELOPMENT 182
16.4 GE HEALTHCARE 183
16.4.1 COMPANY SNAPSHOT 183
16.4.2 REVENUE ANALYSIS 183
16.4.3 PRODUCT PORTFOLIO 184
16.4.4 RECENT DEVELOPMENT 184
16.5 WELLELL INC. 185
16.5.1 COMPANY SNAPSHOT 185
16.5.2 REVENUE ANALYSIS 185
16.5.3 PRODUCT PORTFOLIO 186
16.5.4 RECENT DEVELOPMENT 186
16.6 BMC MEDICAL CO., LTD 187
16.6.1 COMPANY SNAPSHOT 187
16.6.2 REVENUE ANALYSIS 187
16.6.3 PRODUCT PORTFOLIO 188
16.6.4 RECENT DEVELOPMENT 189
16.7 BOPPEL.MED 190
16.7.1 COMPANY SNAPSHOT 190
16.7.2 PRODUCT PORTFOLIO 190
16.7.3 RECENT DEVELOPMENT 191
16.8 CVR MEDICAL SUPPLY. 192
16.8.1 COMPANY SNAPSHOT 192
16.8.2 PRODUCT PORTFOLIO 192
16.8.3 RECENT DEVELOPMENT 193
16.9 ECUMED GMBH. 194
16.9.1 COMPANY SNAPSHOT 194
16.9.2 PRODUCT PORTFOLIO 194
16.9.3 RECENT DEVELOPMENT 195
16.10 FRITZ STEPHAN GMBH 196
16.10.1 COMPANY SNAPSHOT 196
16.10.2 PRODUCT PORTFOLIO 196
16.10.3 RECENT DEVELOPMENT 196
16.11 HAMILTON MEDICAL 197
16.11.1 COMPANY SNAPSHOT 197
16.11.2 PRODUCT PORTFOLIO 197
16.11.3 RECENT DEVELOPMENT 198
16.12 HEYER MEDICAL AG 199
16.12.1 COMPANY SNAPSHOT 199
16.12.2 PRODUCT PORTFOLIO 199
16.12.3 RECENT DEVELOPMENT 200
16.13 HUNAN BEYOND MEDICAL TECHNOLOGY CO., LTD. 201
16.13.1 COMPANY SNAPSHOT 201
16.13.2 PRODUCT PORTFOLIO 201
16.13.3 RECENT DEVELOPMENT 203
16.14 KRANZ GMBH. 204
16.14.1 COMPANY SNAPSHOT 204
16.14.2 PRODUCT PORTFOLIO 204
16.14.3 RECENT DEVELOPMENT 205
16.15 LOWENSTEIN MEDICAL SE & CO. KG. 206
16.15.1 COMPANY SNAPSHOT 206
16.15.2 PRODUCT PORTFOLIO 206
16.15.3 RECENT DEVELOPMENT 210
16.16 NARANG MEDICAL LIMITED 211
16.16.1 COMPANY SNAPSHOT 211
16.16.2 PRODUCT PORTFOLIO 211
16.16.3 RECENT DEVELOPMENTS 212
16.17 NAREENA LIFESCIENCES PVT.LIMITED 213
16.17.1 COMPANY SNAPSHOT 213
16.17.2 PRODUCT PORTFOLIO 213
16.17.3 RECENT DEVELOPMENT 214
16.18 NIHON KOHDEN CORPORATION 215
16.18.1 COMPANY SNAPSHOT 215
16.18.2 REVENUE ANALYSIS 215
16.18.3 PRODUCT PORTFOLIO 216
16.18.4 RECENT UPDATES 216
16.19 SEFAM 217
16.19.1 COMPANY SNAPSHOT 217
16.19.2 PRODUCT PORTFOLIO 217
16.19.3 RECENT UPDATES 218
16.20 SOMNOMEDICS AG. 219
16.20.1 COMPANY SNAPSHOT 219
16.20.2 PRODUCT PORTFOLIO 219
16.20.3 RECENT DEVELOPMENT 221
?
16.21 VYGON 223
16.21.1 COMPANY SNAPSHOT 223
16.21.2 PRODUCT PORTFOLIO 223
16.21.3 RECENT DEVELOPMENT 224
16.22 WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH 225
16.22.1 COMPANY SNAPSHOT 225
16.22.2 PRODUCT PORTFOLIO 225
16.22.3 RECENT DEVELOPMENT 226
17 QUESTIONNAIRE 227
18 RELATED REPORTS 229
?
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.